Close Menu
    Facebook X (Twitter) Instagram
    Latest
    • A new malpractice being observed: Reviewers asking their own papers to cite
    • 100% APC Waiver for Authors from “Group A” Category Countries Indicated by Research4Life
    • Retraction Notice: Pharmacological Actions of Impatiens
    • DOI Allocated and Activated for 281 Articles and Abstracts Published in the period of 2014-2017
    • IGJPS, 2021, Vol 11, Issue 3
    • IGJPS, 2021, Vol 11, Issue 2
    • IGJPS, 2021, Vol 11, Issue 1
    • Table of Contents, Vol 10, Issue 4
    INDO GLOBAL JOURNAL OF PHARMACEUTICAL SCIENCESINDO GLOBAL JOURNAL OF PHARMACEUTICAL SCIENCES
    • Home
    • About Us
    • Issues
      • IGJPS 2022 and Onwards
      • IGJPS, 2021, Vol 11, Issue 3
      • IGJPS, 2021, Vol 11, Issue 2
      • IGJPS, 2021, Vol 11, Issue 1
      • IGJPS, 2020, Vol 10, Issue 4
      • IGJPS, 2020, Vol 10, Issue 3
      • IGJPS, 2020, Vol 10, Issue 2
      • IGJPS, 2020, Vol 10, Issue 1
      • IGJPS, 2019, Vol 9, Issue 2 (Suppl.)
      • IGJPS, 2019, Vol 9, Issue 2
      • IGJPS, 2019, Vol 9, Issue 1
      • IGJPS, 2018, Vol 8, Issue 3
      • IGJPS, 2018, Vol 8, Issue 2
      • IGJPS, 2018, Vol 8, Issue 1
      • IGJPS, 2017, Vol 7, Issue 2
      • IGJPS, 2017, Vol 7, Issue 1
      • IGJPS, 2016, Vol 6, Issue 2
      • IGJPS, 2016, Vol 6, Issue 1
      • IGJPS, 2015, Vol 5, Issue 3
      • IGJPS, 2015, Vol 5, Issue 2
      • IGJPS, 2015, Vol 5, Issue 1
      • IGJPS, 2014, Vol 4, Issue 3
      • IGJPS, 2014, Vol 4, Issue 2
      • IGJPS, 2014, Vol4, Issue 1
      • IGJPS, 2013, Vol 3, Issue 3
      • IGJPS,2013, Vol 3, Issue 2
      • IGJPS, 2013, Vol 3, Issue 1
      • IGJPS, 2012, Vol 2, Issue 4
      • IGJPS, 2012, Vol 2, Issue 3
      • IGJPS, 2012, Vol 2, Issue 2
      • IGJPS, 2012, Vol 2, Issue 1
      • IGJPS, 2011, Vol 1, Issue 4
      • IGJPS, 2011, Vol 1, Issue 3
      • IGJPS, 2011, Vol 1, Issue 2
      • IGJPS, 2011, Vol 1, Issue 1
    • Editorial Board
    • Guidelines For Authors
    • Indexed
    • Manuscript Submission
    • Contact Us
    INDO GLOBAL JOURNAL OF PHARMACEUTICAL SCIENCESINDO GLOBAL JOURNAL OF PHARMACEUTICAL SCIENCES
    You are at:Home»News»100% APC Waiver for Authors from “Group A” Category Countries Indicated by Research4Life

    100% APC Waiver for Authors from “Group A” Category Countries Indicated by Research4Life

    0
    By Rajeev Singla on May 13, 2022 News, Slider

    We have observed the policies of Research4Life and would like to comply with their objectives by providing 100% APC waivers to the authors belonging to the countries from “Group A” categories. In order to be eligible, the first author and corresponding author should be from the “Group A” category countries. The purpose is to support those researchers and remove the hindrance of Article Processing Charges for them. 

    Group A countries are as below:

    • Afghanistan
    • Angola
    • Bangladesh
    • Belize
    • Benin
    • Bhutan
    • Burkina Faso
    • Burundi
    • Cambodia
    • Cameroon
    • Cabo Verde
    • Central African Republic
    • Chad
    • Comoros
    • Congo
    • Cook Islands
    • Côte d’Ivoire
    • Democratic People’s Republic of Korea
    • Democratic Republic of the Congo
    • Djibouti
    • Dominica
    • Equatorial Guinea
    • Eritrea
    • Eswatini
    • Ethiopia
    • Gambia
    • Ghana
    • Grenada
    • Guinea
    • Guinea-Bissau
    • Guyana
    • Haiti
    • Kenya
    • Kiribati
    • Kyrgyzstan
    • Lao People’s Democratic Republic
    • Lesotho
    • Liberia
    • Madagascar
    • Malawi
    • Maldives
    • Mali
    • Marshall Islands
    • Mauritania
    • Micronesia (Federated States of)
    • Mozambique
    • Myanmar
    • Nauru
    • Nepal
    • Nicaragua
    • Niger
    • Niue
    • Palau
    • Papua New Guinea
    • Republic of Moldova
    • Rwanda
    • Saint Helena
    • Saint Lucia
    • Saint Vincent and the Grenadines
    • Samoa
    • Sao Tome and Principe
    • Senegal
    • Sierra Leone
    • Solomon Islands
    • Somalia
    • South Sudan
    • Sudan
    • Suriname
    • Syrian Arab Republic
    • Tajikistan
    • Timor-Leste
    • Togo
    • Tokelau
    • Tonga
    • Tuvalu
    • Uganda
    • United Republic of Tanzania
    • Vanuatu
    • Yemen
    • Zambia
    • Zimbabwe

    This policy will be effective from 13th May 2022 and will be applicable for all the publications submitted from 2022 onwards. 

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

    Related Posts

    A new malpractice being observed: Reviewers asking their own papers to cite

    Retraction Notice: Pharmacological Actions of Impatiens

    DOI Allocated and Activated for 281 Articles and Abstracts Published in the period of 2014-2017

    Comments are closed.

    Latest News
    A new malpractice being observed: Reviewers asking their own papers to cite
    ...
    100% APC Waiver for Authors from “Group A” Category Countries Indicated by Research4Life
    ...
    Retraction Notice: Pharmacological Actions of Impatiens
    ...
    DOI Allocated and Activated for 281 Articles and Abstracts Published in the period of 2014-2017
    ...
    Top Peer Reviewer as New Associate Editor: Dr. Ghulam Md. Ashraf, King Abdulaziz University, Jeddah, Saudi Arabia
    ...
    Highly Cited Articles

    Microencapsulation–A Novel Approach in Drug Delivery: A Review

    Review on the pharmacognostical & pharmacological characterization of Apium graveolens Linn


    Medicinal Plants of Rural India: A Review of Use by Indian Folks


    Self Emulsifying Drug Delivery System: A Tool in Solubility Enhancement of Poorly Soluble Drugs


    Antioxidant and antimicrobial activities of Cocos nucifera Linn.(Arecaceae) endocarp extracts

    Impotant Links
    • About Us
    • Call For Papers
    • Contact Us
    • Editorial Board
    • For Reviewers
    • Guidelines For Authors
    • Home Page
    • Indexed
    • Issues
    • Manuscript Submission
    • Checkout
    • Transaction Results
    • Your Account
    Sponsored
    Copyright © 2011 iGlobal Research & Publishing Foundation
    Powered By :- Ganga Graphix.

    Type above and press Enter to search. Press Esc to cancel.